Related Experiment Video
Updated: Jul 4, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Henoch-Schönlein purpura]
Evangéline Pillebout1, Patrick Niaudet
1Service de néphrologie et de transplantation, hôpital Saint-Louis, Paris. evangeline.pillebout@sls.aphp.fr
La Revue Du Praticien
|June 6, 2008
Summary
Henoch-Schönlein purpura (HSP) is an IgA vasculitis impacting small vessels, primarily affecting children. While often self-limiting, severe cases, especially in adults, can lead to significant kidney damage and end-stage renal failure.
Area of Science:
- Immunology
- Rheumatology
- Nephrology
Background:
- Henoch-Schönlein purpura (HSP) is a systemic IgA vasculitis affecting small blood vessels.
- Key manifestations include skin purpura, arthritis, gastrointestinal issues, and potential nephritis with IgA deposits.
- While common in children, HSP is rarer and more severe in adults, often presenting with significant nephritis.
Purpose of the Study:
- To review the immunopathogenesis, clinical features, and prognosis of Henoch-Schönlein purpura.
- To highlight the role of IgA in HSP.
- To discuss treatment strategies for HSP, particularly severe nephritis.
Main Methods:
- Literature review of Henoch-Schönlein purpura.
- Analysis of clinical features and immunopathogenesis.
- Evaluation of short-term and long-term outcomes, including renal involvement.
Main Results:
- IgA plays a central role in the immunopathogenesis of HSP.
- Prognosis is dictated by the severity of gastrointestinal symptoms and nephritis.
- Up to one-third of patients may progress to end-stage renal failure.
Conclusions:
- Symptomatic treatment is recommended for self-limited HSP.
- Management of severe HSP nephritis remains debated, with potential benefits from corticosteroids and immunosuppressants requiring further confirmation.
Related Concept Videos
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...